Advanced Breast Cancer Treatment Ibrance (Palbociclib)

Ibrance (palbociclib) is an FDA approved hormone based treatment for metastatic breast cancer. This cancer drug treats patients who are post menopausal and whose advanced cancer tests positive for an estrogen receptor (ER) as well as tests negative for the HER2 protein. Oncologist Dr. Stephen Lemon talks about how Ibrance works, as well as covers some of the side effects it may cause.

Click on the buttons below to view more videos that we have produced

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email